摘要 |
The present invention provides a pyrazolopyrimidine compound of the formula [I]:
wherein R 1 is
(A) a substituted aryl group,
(B) an optionally substituted nitrogen-containing aliphatic heteromonocyclic group,
(C) a substituted cyclo-lower alkyl group,
(D) an optionally substituted amino group, or
(E) a substituted heteroaryl group,
R 2 is (a) an optionally substituted heteroaryl group or (b) an optionally substituted aryl group,
Y is a single bond, a lower alkylene group or a lower alkenylene group,
Z is a group of the formula: -CO-, -CH 2 -, -SO 2 or a group of the formula:
Q is a lower alkylene group, and q is an integer of 0 or 1 or a pharmaceutically acceptable salt thereof, which has a small conductance potassium channel (SK channel) blocking activity and is useful as a medicament and a process for preparing the same.
|
申请人 |
MITSUBISHI TANABE PHARMA CORPORATION |
发明人 |
TAKAMURO, IWAO;SEKINE, YASUO;TSUBOI, YASUNORI;NOGI, KOUJI;TANIGUCHI, HIROYUKI |